DERM
|Journey Medical Corp
NASDAQ
USD 6.99
-0.36|-4.90%
Current Price
USD 6.99
Change
USD -0.36 (-4.90%)
P/E Ratio
Dividend Yield
Market Cap
172.16M
Volume
124,725
Open
USD 7.30
Previous Close
USD 7.35
52-Week High
USD 8.25
52-Week Low
USD 3.54
About Journey Medical Corp
Journey Medical Corporation focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company's marketed products include Qbrexza, a medicated cloth towelette for the treatment of primary axillary hyperhidrosis; Accutane, an oral isotretinoin drug to treat severe recalcitrant nodular acne; and Amzeeq, a topical formulation of minocycline for the treatment of inflammatory lesions of non-nodular moderate to ...
Sector:Healthcare
Industry:Drug Manufacturers - Specialty & Generic
CEO:Mr. Claude Maraoui
Employees:41
Headquarters:Scottsdale, USA
Website:journeymedicalcorp.com
Similar Companies
Explore Stocks by Sector
technology
finance
healthcare
Frequently Asked Questions